Junyan Chen is currently the Executive Director/CRP at Eli Lilly and Company, having held multiple leadership roles within the organization since 2020, including Sr. Director of ASCVD early development. Previously, Junyan served as a Senior Health Science Advisor at MSD from 2011 to 2013 and held various positions at Novartis and Amgen, where they contributed significantly to projects like the Repatha launch. Junyan’s extensive experience in the pharmaceutical industry has equipped them with a robust background in cardiovascular research and development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices